Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.10.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 30, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
[1]
Other current liabilities   $ 69   $ 69   $ 250
Contingent obligation   1,821   1,821   1,662
General and administrative expense   1,740 $ 840 3,876 $ 2,493  
Other long-term liabilities   66   66  
Financing expense   81 $ 69 159 $ 134  
License and Supply Agreement (Coated Products) [Member]            
Description of royalty payment

a. 2% of the first $25 million in annual net sales of Coated Products; and

b. 1.5% once annual net sales exceed $25 million of Coated Products.

         
Description of minimum royalty payment

a. January 1, 2020 to December 31, 2020 - $5 per calendar quarter;

b. January 1, 2021 to December 31, 2021 - $10 per calendar quarter;

c. January 1, 2022 and beyond - $15 per calendar quarter.

         
Description of royalty payment for one-time milestone

a. $12.5 due 6 months after the first commercial sale of a Coated Product.

b. $12.5 due 12 months after the first commercial sale of a Coated Product.

c. $25 due 18 months after the first commercial sale of a Coated Product.

         
Other current liabilities   25   25    
General and administrative expense   0   50    
Other long-term liabilities   25   $ 25    
Royalty Arrangements To Israel Innovation Authority [Member]            
Description of royalty payment      
Royalties ranging from 3% to 3.5% of revenues on sales of products and services based on technology developed using IIA grants, up to an aggregate of 100% (which may be increased under certain circumstances) of the U.S. dollar-linked value of the grant, plus interest at the rate of 12-month LIBOR.
   
Royalty received       $ 1,332    
Contingent obligation   $ 1,379   $ 1,379    
[1] Derived from audited consolidate financial statements.